欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5640/001
药品名称Tranexaminezuur Kabi 10 mg/ml solution for infusion
活性成分
    • tranexamic acid 10.0 mg/ml
剂型Solution for infusion
上市许可持有人Fresenius Kabi Nederland B.V. Amersfoortseweg 10 E 3712 BC Utrecht The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Tranexaminezuur Kabi 10 mg/ml oplossing voor infusie
互认成员国 - 产品名称
    • Austria (AT)
    • Czechia (CZ)
      Tranexamic acid Kabi
    • Portugal (PT)
    • Romania (RO)
      Acid tranexamic Kabi 10 mg/ml soluție Perfuzabilă
    • Greece (GR)
    • Slovakia (SK)
    • Sweden (SE)
    • United Kingdom (Northern Ireland) (XI)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
    • Lithuania (LT)
      Tranexamic acid Kabi 10 mg/ml infuzinis tirpalas
    • Estonia (EE)
    • Germany (DE)
    • Hungary (HU)
      Tranexámsav Kabi 10 mg/ml oldatos infúzió
    • Denmark (DK)
      Tranexamic acid Kabi
    • Bulgaria (BG)
      Tranexamic Acid Kabi
    • Belgium (BE)
    • Cyprus (CY)
      Tranexamic acid/Kabi 10 mg/ml διάλυμα για έγχυση
许可日期2023/11/08
最近更新日期2024/05/23
药物ATC编码
    • B02AA02 tranexamic acid
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase